BioSpace News Archive

Deals

Cantel Medical Reports Financial Results for its Third Quarter Fiscal Year 2019

Cantel Medical Corp. announced financial results for its third quarter ended April 30, 2019.

June 4, 2019
·
5 min read
Genetown

Innovation and Unmet Need Drive Prescription Drug Sales to $1.18tr by 2024: New Report from Evaluate Ltd

“EvaluatePharma® World Preview 2019, Outlook to 2024” explores growth drivers, growth brakes and top industry performers.

June 4, 2019
·
2 min read
Bio NC

IQVIA’s OCE Technology Platform Selected by Zambon to Establish a Global Multichannel Commercial Engagement Model for OTC Business

Italian multinational pharmaceutical company to coordinate all physical and digital activities with pharmacists using IQVIA Technologies’ end-to-end solution.

June 4, 2019
·
4 min read
Policy

Glytec Developing Novel Solution for Selection and Dosing of All Diabetes Medications

New product will be the market’s first and only to enable optimization of ALL diabetes medications, insulin and non-insulin alike.

June 4, 2019
·
6 min read
Biotech Beach

Agilent Survey of Pharma Lab Leaders Uncovers Challenges in Workflow and Laboratory Efficiencies

Respondents included 650 laboratory managers, directors, and supervisors from China, Germany, India, South Korea, Switzerland, Austria, and the United States.

June 4, 2019
·
3 min read
Business

NantKwest Announces Durable Complete Responses in Multiple Advanced-Stage Solid Tumor Cancers Following Off-the-Shelf NK Cell Therapy in First 35 Patients

5 out of 35 Durable Complete Responses Observed in Patients with Relapsed Third-Line Advanced Solid Tumors with Duration Ranging 4 to 24 Months

June 4, 2019
·
5 min read
Bio NC

Allbridge Named to List of 2019 Best Employers in North Carolina

This survey and awards program was designed to identify, recognize, and honor the best employers in North Carolina, benefiting the economy, workforce, and businesses.

June 4, 2019
·
3 min read
Business

Theravance Biopharma Appoints Andrew Hindman as Senior Vice President and Chief Financial Officer

Experienced Life Science Industry Executive with Strong Track Record of Long-Term Value Creation and Broad Therapeutic Expertise

June 4, 2019
·
7 min read
Drug Development

Dance Biopharm to Present Data from Phase 2 Clinical Trial of Dance 501 Inhaled Insulin Therapy at American Diabetes Association Meeting

This trial, conducted in patients with type 2 diabetes, compared three doses each of Dance 501 inhaled insulin and subcutaneous insulin lispro

June 4, 2019
·
2 min read
Business

CNS Summit Announces the Initial List of Speakers for its 10ᵗʰ Anniversary

CNS Summit announced the initial list of speakers for the 10th Anniversary Summit.

June 4, 2019
·
1 min read